JY
BFRI icon

Jeff Yass’s Biofrontera BFRI Stock Holding History

Jeff Yass’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,574
Closed -$31.2K – 13384
2026
Q1 		$31.2K Buy
38,574
+27,028
+234% +$23.3K ﹤0.01% 12755
2025
Q4 		$6.58K Buy
+11,546
New +$10.4K ﹤0.01% 12082
2022
Q1 		– Sell
-2,551
Closed -$384K – 12977
2021
Q4 		$384K Buy
+2,551
New +$279K ﹤0.01% 9888

Other funds holding BFRI

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Jeff Yass's BFRI Position: Q2 2026 in Review

Jeff Yass sold out of Biofrontera (BFRI) in Q2 2026, closing a stake of 38,574 shares — an estimated $31.2K sold.

Jeff Yass first reported a position in BFRI in Q4 2021 and held it in 3 quarters. The position peaked at $384K in Q4 2021. 19 funds tracked by Wall St. Rank hold BFRI as of Q2 2026.

  • Jeff Yass reported no remaining Biofrontera position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 38,574 Biofrontera shares in Q2 2026, an estimated $31.2K.
  • Jeff Yass first reported a position in Biofrontera in Q4 2021 and held it in 3 quarters.
  • Jeff Yass's Biofrontera position peaked at $384K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.